When we looked at studies around the behavior changes that happen on GLP-1s, we used that data to create a model of total estimated monthly savings of $670 which has annual savings potential of $8,040
Pharmaceutical Experience : You need someone who understands the complexities of pharmaceutical litigation and has experience handling cases against large drug companies like Novo Nordisk or Eli Lilly
GLP-1 inhibits glucagon secretion by acting on islet cells, and islet cells can increase GLP-1 production and secretion capacity
On the other hand, mog-3(-) worms exhibit unique upregulation of transmembrane transport/solute carrier genes
We monitor for this explicitly
doi:10.1056/NEJMoa2500969 Wharton S, Aronne LJ, Stefanski A, et al